Al Khayyat Investments has revealed that its BinSina brand has made the move into Oman with the launch of a flagship unit in Muscat.
This entry into Oman marks another step forward in AKI’s growth plans across the Middle East and North Africa region, which encompasses over 5,500 employees working across AKI’s various business divisions.
“People today not only desire access to a diverse range of health offerings, but exceptional customer services and experiences when they shop. With a deep knowledge of the region’s retail and healthcare sectors, we realised that this is the right moment for us to explore more opportunities in Oman with our BinSina Pharmacy brand. It is one of several exciting projects in the country and part of our wider expansion plans across the MENA region,” said Zaid S. Al Khayyat, Managing Director of Al Khayyat Investments (AKI).
“Over the years, BinSina has become a name synonymous with the best products and services in the pharma sector. The ongoing success of BinSina Pharmacy allows us to continue growing and expanding our network of pharmacies in the GCC. With that opportunity, we are excited to bring our innovative and modernised approach to managing pharmacies and customer experiences to Oman,” said Dr. Doaa Marouf, Chief Executive Officer of Al Khayyat Investments (AKI) Pharma.
